G. Szilágyi - Concepedia

Author

G. Szilágyi

Also Known As

G SZILAGYI, G Szilagyi, G Szilágyi, G. SZILAGYI, G. SZILÁGYI, G. Szilagyi, G. Szilágyi, GEZA SZILAGYI, Geza Szilagyi, GÉZa Szilágyi

180

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Semmelweis University Hungarian Academy of Sciences Karolinska Institutet Szent Imre Egyetemi Oktatókórház Gedeon Richter (Hungary)

About

G. Szilágyi is an author at Semmelweis University specializing in medicine, pharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	18	445
2	Natural Sciences	5	5	98
3	Health Sciences	3	3	52
4	Engineering	2	2	24
5	Public Health	2	2	62

G. Szilágyi

Publications

854

Citations

H-Index

Page 1

	Year	Citations
Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long‐term iodine prophylaxis and abundant iodine intake I. Szabolcs, J Podoba, Joachim Feldkamp, Clinical Endocrinology	1997	140
The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism Lajos Kovács, MI Goth, I. Szabolcs, European Journal of Endocrinology	1998	65
Low dehydroepiandrosterone sulfate (DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors. Zsuzsa Bencsik, I. Szabolcs, Zsolt Kovács, The Journal of Clinical Endocrinology & Metabolism Hormonal ActivityAdrenal GlandUrologyAdrenal TumorsMedicine	1996	50
Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study G. Szilágyi, László Balkay, István Boros, Journal of the Neurological Sciences Cerebral Vascular RegulationPet StudyGlucose MetabolismIschemic StrokeCardiovascular Disease	2005	50
[11C]Vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies Balázs Gulyás, Christer Halldin, Ádám Vas, Journal of the Neurological Sciences Pharmacological StudyMedicineNeuropharmacologyPrimate Pet StudiesExperimental Pharmacology	2004	48
Visualization of mitochondrial membrane potential and reactive oxygen species via double staining G. Szilágyi, L Simón, Péter Koska, Neuroscience Letters BiologyMitochondrial FunctionBiochemistryMedicineNatural Sciences	2006	43
Correlation between crossed cerebellar diaschisis and clinical neurological scales G. Szilágyi, Ádám Vas, Levente Kerényi, Acta Neurologica Scandinavica	2011	40
(−)-d-Deprenyl attenuates apoptosis in experimental brain ischaemia L Simón, G. Szilágyi, Zoltán Bori, European Journal of Pharmacology Neurodegenerative DiseasesMedicineApoptosisExperimental Brain IschaemiaCell Death	2001	35
1,2,4‐Triazoles, VI<sup>1)</sup>: Synthesis of New 1,5‐Diphenyl‐3‐<i>H</i>‐1,2,4‐triazoles Substituted with H‐, Alkyl, or Carboxyl Groups at C‐3 L. Czollner, G. Szilágyi, József Langó, Archiv der Pharmazie	1990	31
Low dose (−)deprenyl is cytoprotective: It maintains mitochondrial membrane potential and eliminates oxygen radicals L Simón, G. Szilágyi, Zoltán Bori, Life Sciences OxysterolHealth SciencesMitochondrial FunctionLow DoseMedicine	2005	31

Page 1